llumina to buy venture-backed GenoLogics Life Sciences Software
Illumina Inc (Nasdaq: ILMN) has agreed to buy GenoLogics Life Sciences Software Inc, a Canadian developer of laboratory information management systems for life sciences organizations. The financial terms of the deal were not published. Immunia said the purchase will strengthen its portfolio of genetic analysis solutions. Headquartered in Victoria, British Columbia, GenoLogics' technology has been adopted by over 120 genomic labs worldwide. Founded in 2002, it has raised over US$20 million in funding, according to Thomson Reuters. GenoLogics' investors include Canadian venture capital firms GrowthWorks and Yaletown Venture Partners and U.S. firm OVP Venture Partners.
6 August 2015•3 mins read
